enVVeno Medical

-$0.06 (-1.46%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NVNO and other ETFs, options, and stocks.

About NVNO

enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve.

CEO
Robert Andrew Berman
Employees
24
Headquarters
Irvine, California
Founded
1999

NVNO Key Statistics

Market cap
38.45M
Price-Earnings ratio
—
Dividend yield
—
Average volume
21.04K
High today
$4.13
Low today
$4.01
Open price
$4.01
Volume
14.43K
52 Week high
$11.38
52 Week low
$3.88

NVNO Earnings

-$0.94
-$0.63
-$0.31
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 1, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure